ATE125170T1 - Maltodextrin-entschäumungszusammensetzung. - Google Patents

Maltodextrin-entschäumungszusammensetzung.

Info

Publication number
ATE125170T1
ATE125170T1 AT90830450T AT90830450T ATE125170T1 AT E125170 T1 ATE125170 T1 AT E125170T1 AT 90830450 T AT90830450 T AT 90830450T AT 90830450 T AT90830450 T AT 90830450T AT E125170 T1 ATE125170 T1 AT E125170T1
Authority
AT
Austria
Prior art keywords
defoaming
maltodextrin
weight percent
composition
defoaming composition
Prior art date
Application number
AT90830450T
Other languages
English (en)
Inventor
William Valentine
William K Valentine
Original Assignee
Valentine Enterprises Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valentine Enterprises Inc filed Critical Valentine Enterprises Inc
Application granted granted Critical
Publication of ATE125170T1 publication Critical patent/ATE125170T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • B01D19/0404—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Degasification And Air Bubble Elimination (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT90830450T 1989-10-19 1990-10-10 Maltodextrin-entschäumungszusammensetzung. ATE125170T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/423,877 US5073384A (en) 1989-10-19 1989-10-19 Maltodextrin/defoaming composition combinate

Publications (1)

Publication Number Publication Date
ATE125170T1 true ATE125170T1 (de) 1995-08-15

Family

ID=23680536

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90830450T ATE125170T1 (de) 1989-10-19 1990-10-10 Maltodextrin-entschäumungszusammensetzung.

Country Status (6)

Country Link
US (1) US5073384A (de)
EP (1) EP0425450B1 (de)
JP (1) JPH0815521B2 (de)
AT (1) ATE125170T1 (de)
CA (1) CA2026030C (de)
DE (1) DE69021007T2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112044119A (zh) * 2020-09-07 2020-12-08 安徽銮威化工科技开发有限公司 一种pvc用有机硅消泡剂及其制备方法

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
DE4140116A1 (de) * 1991-12-05 1993-06-09 Bolder Arzneimittel Gmbh Dimeticon-pastillen
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
FR2705966B1 (fr) * 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
WO1995015537A1 (en) * 1993-11-30 1995-06-08 Arch Development Corporation Automated method and system for the alignment and correlation of images from two different modalities
EP0773866B1 (de) * 1994-08-03 1998-04-08 Gunter Meinhardt Voss Verfahren zur herstellung von manteltabletten
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
GB9523136D0 (en) * 1995-11-11 1996-01-10 Procter & Gamble Silicone-containing powders
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5908636A (en) * 1996-06-28 1999-06-01 Mcneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
JP3001440B2 (ja) * 1996-11-25 2000-01-24 日本電気通信システム株式会社 仮想ｌａｎ方式
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
MXPA01001969A (es) * 1998-08-25 2002-04-24 Platt Chris Tableta de liberacion temporizada que comprende naproxen y pseudoefedrina.
FR2803720B1 (fr) * 2000-01-18 2004-10-22 Roquette Freres Lozenges a base de dextrose et leur procede de fabrication
US6399591B1 (en) 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets
EP1256347A1 (de) * 2001-05-10 2002-11-13 Swiss Caps Rechte und Lizenzen AG Verwendung von Stärke zur Herstellung eines Mittels für eine therapeutische Behandlung
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
JP5457830B2 (ja) 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
JP2011173786A (ja) * 2010-02-23 2011-09-08 Dow Global Technologies Llc セメントスラリーのためのレオロジー調整剤
CN101804199B (zh) * 2010-03-30 2012-07-25 四川健能制药有限公司 一种用于消化道的药物组合物及其应用
GB201014041D0 (en) 2010-08-23 2010-10-06 Biofilm Ltd Soluble film
EP2649172A1 (de) 2010-12-10 2013-10-16 Dow Corning Corporation Schaumregulierende zusammensetzung in granulatform
GB201021170D0 (en) 2010-12-10 2011-01-26 Dow Corning Granulated organopolysiloxane products
JP2013103204A (ja) * 2011-11-16 2013-05-30 Shin-Etsu Chemical Co Ltd 粉末消泡剤及びその製造方法
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
RU2014149581A (ru) 2012-06-12 2016-07-10 Дзе Проктер Энд Гэмбл Компани Шипучая лекарственная форма
JP6026859B2 (ja) * 2012-11-16 2016-11-16 楠本化成株式会社 水性塗料用消泡剤の消泡性改良剤
JP5969360B2 (ja) * 2012-11-19 2016-08-17 楠本化成株式会社 揮発分のない水性塗料用消泡剤
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
WO2016200345A1 (en) 2015-06-12 2016-12-15 Santa Farma İlaç Sanayi̇ A. Ş. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics.
MX385008B (es) * 2016-12-14 2025-03-14 Rhein Siegfried Sa De Cv Composicion mejorada de lansoprazol y simeticona y procesos para prepararla.
JP2023533486A (ja) * 2020-07-03 2023-08-03 アーラ フーズ アンバ 中性インスタント飲料ホエイプロテイン粉末
CN112263851A (zh) * 2020-09-30 2021-01-26 四川健能制药有限公司 一种二甲硅油消泡组合物的制备方法
JP2024544741A (ja) 2021-11-16 2024-12-03 ジョンソン アンド ジョンソン コンシューマー インク． シメチコンを含有するカスタマイズ可能な剤形

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA508856A (en) * 1955-01-04 Shell Development Company Non-foaming detergents
US2441098A (en) * 1946-09-09 1948-05-04 Corning Glass Works Methyl siloxane polymers and method of preparation
US2774710A (en) * 1952-12-15 1956-12-18 Organon Pharmaceutical preparation for the treatment of hyperacidity
NL120374C (de) * 1959-07-20
US3207698A (en) * 1963-02-13 1965-09-21 Nopco Chem Co Composition and method for defoaming aqueous systems
US3304266A (en) * 1963-05-06 1967-02-14 Dow Corning Foam control agents
US3388073A (en) * 1963-12-16 1968-06-11 Nalco Chemical Co Process of defoaming and inhibiting foam formation in aqueous systems
US3326754A (en) * 1965-06-10 1967-06-20 Rexall Drug Chemical Method of relieving gastrointestinal distress with tributyl phosphate
IL26885A (en) * 1965-12-06 1970-10-30 Smith Kline French Lab Pharmaceutical silicone compositions
US3849194A (en) * 1966-12-19 1974-11-19 Cpc International Inc Low d.e. starch conversion products
USRE30880E (en) * 1967-03-24 1982-03-09 Grain Processing Corporation Low D.E. starch conversion products
US3528929A (en) * 1967-05-24 1970-09-15 Buckman Labor Inc Defoaming,deaerating,and drainage aid compositions
US3663369A (en) * 1968-02-23 1972-05-16 Grain Processing Corp Hydrolysis of starch
DE1914684B2 (de) * 1969-03-22 1975-12-04 Th. Goldschmidt Ag, 4300 Essen Entschäumeremulsion
DE1936126C3 (de) * 1969-07-16 1973-12-06 Bayer Ag, 5090 Leverkusen Entschäumer
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
US3909445A (en) * 1970-03-18 1975-09-30 Mobil Oil Corp Method for reducing foam in water containing systems
US3714068A (en) * 1970-12-28 1973-01-30 Philadelphia Quartz Co Silica
US3705859A (en) * 1970-12-30 1972-12-12 Hercules Inc Method of abating foam formation in aqueous systems
US4298400A (en) * 1971-01-18 1981-11-03 Grain Processing Corporation Low D.E. starch conversion products
GB1378874A (en) * 1971-07-01 1974-12-27 Dow Corning Ltd Foam control substance
US3784479A (en) * 1972-05-15 1974-01-08 Dow Corning Foam control composition
BE788249A (fr) * 1972-05-15 1973-02-28 Dow Corning Compositions de silicones pour lutter contre le moussage dans les procedes de teinture au jet
US4102823A (en) * 1972-12-08 1978-07-25 The Procter & Gamble Company Low and non-phosphate detergent compositions
US4115553A (en) * 1973-12-10 1978-09-19 Armour Pharmaceutical Company Antacid tablets
US3912652A (en) * 1973-12-17 1975-10-14 Dow Corning Defoaming composition useful in jet dyeing
US3959176A (en) * 1974-09-09 1976-05-25 Drew Chemical Corporation Non-foaming dispersing composition
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4230693A (en) * 1975-04-21 1980-10-28 Armour-Dial, Inc. Antacid tablets and processes for their preparation
US4180485A (en) * 1977-11-02 1979-12-25 The Procter & Gamble Company Spray-dried detergent compositions
CH636123A5 (de) * 1978-06-07 1983-05-13 Ciba Geigy Ag Verfahren zur herstellung schaumregulierter waschmittel.
US4386106A (en) * 1981-12-01 1983-05-31 Borden, Inc. Process for preparing a time delayed release flavorant and an improved flavored chewing gum composition
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4698264A (en) * 1982-08-02 1987-10-06 Durkee Industrial Foods, Corp. Particulate composition and process for making same
US4514319A (en) * 1983-03-25 1985-04-30 Union Carbide Corporation Antifoam composition containing hydrocarbon-silicon copolymer, hydrophobic filler and hydrocarbon oil
US4497832A (en) * 1983-04-18 1985-02-05 Warner-Lambert Company Chewing gum composition having enhanced flavor-sweetness
JPS59222209A (ja) * 1983-05-30 1984-12-13 Shin Etsu Chem Co Ltd 固形消泡剤
US4581381A (en) * 1983-11-14 1986-04-08 Nabisco Brands, Inc. Soft homogeneous antacid tablet
JPS6142309A (ja) * 1984-08-06 1986-02-28 Shin Etsu Chem Co Ltd 粉末消泡剤
US4590075A (en) * 1984-08-27 1986-05-20 Warner-Lambert Company Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8521956D0 (en) * 1985-09-04 1985-10-09 Unilever Plc Antifoam ingredient
US5004595A (en) * 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US4804543A (en) * 1987-07-14 1989-02-14 Warner-Lambert Company Novel hydrophilic plasticizing system and chewing gum containing same
US5024937A (en) * 1989-04-06 1991-06-18 Dow Corning Corporation Method for processing aqueous fermentation broths

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112044119A (zh) * 2020-09-07 2020-12-08 安徽銮威化工科技开发有限公司 一种pvc用有机硅消泡剂及其制备方法

Also Published As

Publication number Publication date
DE69021007T2 (de) 1996-03-21
EP0425450A3 (de) 1991-07-10
JPH03151005A (ja) 1991-06-27
EP0425450A2 (de) 1991-05-02
DE69021007D1 (de) 1995-08-24
JPH0815521B2 (ja) 1996-02-21
EP0425450B1 (de) 1995-07-19
CA2026030C (en) 1997-04-01
US5073384A (en) 1991-12-17
CA2026030A1 (en) 1991-04-20

Similar Documents

Publication Publication Date Title
DE69021007D1 (de) Maltodextrin-Entschäumungszusammensetzung.
ATE319435T1 (de) Entschäumende zusammensetzung
ZA912580B (en) Thiophene sulfonamides useful as carbonic anhydrase inhibitors
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ES2159524T3 (es) Preparacion farmaceutica para administrarse en el interior de las vias respiratorias.
ATE119766T1 (de) Zubereitung für den magen.
MXPA99009542A (de)
KR870007703A (ko) 약제 현탁액 투여용 장치
FR2643233B1 (fr) Composition absorbant l'oxygene, procede pour sa formulation et sachet la contenant
NO923590L (no) Doseringsform for avgivelse av medikament til tarmen
NO160330C (no) Anordning for aa administrere medikamenter til pasienter og medikamentpakning for anordningen.
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
KR830005846A (ko) 치과용 조성물
IT9047659A0 (it) Composizione farmaceutica contenente ranitidina sotto forma di capsule di gelatina.
AU630740B2 (en) Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
CA2046533A1 (en) Treatment of endometriosis
SE8400723D0 (sv) Farmaceutisk komposition
DE69002822D1 (de) Pharmazeutische zubereitung zur oralen verabreichung in fluessiger form.
DE69414622D1 (de) Streptogramine in gereinigte Form, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0391852A3 (de) Arzneimittelzusammensetzungen
KR870010082A (ko) 구아르(guar) 분말
MY101916A (en) Etoposide oral dosage form.
IL113816A0 (en) Pharmaceutical compositions containing desogestrel their preparation and use
KR920019369A (ko) 위장병에 유용한 제약학적 복합 성분물
KR910004181A (ko) 생체내 유효성을 증가시키는 신규의 제약학적 경구 투여 형태

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties